--

Founded in 1999, BGI is one of the world's leading life science and genomics organizations. BGI's mission is to use genomics to benefit mankind and to be a leader in the era of life sciences. BGI follows a genomics development model of "research, production and application". With businesses in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. At the same time, BGI provides equipment, technical support and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. BGI is committed to applying its genetic and technological achievements to real world settings in order to realize the dream of trans-omics for a better life.

AstraZeneca is a global, science-led biopharmaceutical company, based in Cambridge, UK. Since entering China in 1993, AstraZeneca has focused on the utmost needs of Chinese patients covering therapy areas of oncology, cardiovascular, renal, metabolism, respiratory, gastrointestinal, rare diseases, vaccine and antibody and immunology, bringing over 40 global innovative medicines to China. AstraZeneca has established its China headquarters in Shanghai, with two global strategic R&D centers located in Shanghai and Beijing. We have also established regional headquarters in Beijing, Guangzhou, Hangzhou, Chengdu and Qingdao. Our global manufacturing sites in Wuxi, Taizhou, and Qingdao are providing high quality medicines to over 70 global markets.

Established in April, 2002, Lanzhou Ion Therapy Co., Ltd. is a high-tech company, which is a subordinate to CAS Ion Medical Technology Co., Ltd. There are more than 400 employees, most of whom hold a bachelor's degree or higher; it is one of the few enterprises in China that has the qualifications and capabilities for the design, production, commissioning, operation and maintenance of heavy ion medical machine (ie carbon ion therapy systems); the company has successively passed ISO9001, 13485 quality management system certification, and obtained relevant qualifications such as Class III medical device production and operation license, Class I radiation device radiation safety license and other relevant qualifications.

Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally.

Winner Medical is a healthcare company headquartered in Shenzhen, Guangdong Province, China, that drives synergistic development between its medical and consumer divisions through two major brands: ""Winner Medical"" and ""Purcotton."" Winner Medical continuously innovates and expands its industry boundaries, with business operations now covering a wide range of sectors including healthcare, personal care, home care, maternal and infant care, and home textiles and apparel.

Lanzhou Foci Pharmaceutical Co., Ltd., a "China Time-honored Brand" with nearly a century of pharmaceutical history, was established in Shanghai in 1929. It pioneered the concentrated pill form of traditional Chinese medicine and was the first Chinese enterprise to engage in the industrial manufacture of traditional Chinese medicine. Listed on the Shenzhen Stock Exchange in 2011, the company is dedicated to the production, contract manufacturing, and sales of traditional Chinese patent medicines and Chinese herbal materials. The Foci trademark is a China-famous trademark. As a high-tech enterprise, it currently boasts 8 R&D platforms, 467 production approval numbers, and 10 exclusive products. Foci products have always maintained a 100% market inspection pass rate. They have been exported to 32 countries and regions across the globe. For many years, the company has consistently ranked among China's top ten traditional Chinese patent medicine-exporting enterprises.

Xinbaotang was founded in the 34th year of the Guangxu reign (1908 AD). It is a "Chinese time-honored brand" enterprise with a history of 116 years and a profound brand culture. It is a provincial-level inheritor unit of the national intangible cultural heritage "Xinhui Chenpi Processing Technology" and a provincial-level demonstration base for the production protection of intangible cultural heritage. It is also a "Guangchenpi Ecological Planting Demonstration Base and Origin Processing Technology Demonstration" approved by the Ministry of Science and Technology of China. It is a leading enterprise in the Science and Technology Innovation Zone of Xinhui Chenpi National Modern Agricultural Industrial Park, a national high-tech enterprise, and a key agricultural leading enterprise in Guangdong Province.

Hubei Tea Group Co., Ltd. is an enterprise directly affiliated to the Hubei Provincial Supply and Marketing Cooperatives, a key leading enterprise of agricultural industrialization at the provincial level,and the president unit of Hubei Provincial Tea Association. The Group's predecessor was the Central South Region Company of China Tea Company, which was established in 1950.The Group has nine member enterprises.With a holistic industry chain, the Hubei Tea Group is a comprehensive professional enterprise that integrates tea planting, production, processing, research and development, domestic sales, export, tea tourism integration, exhibition service and cultural promotion.Its main assortment ranges from "Green Brick Tea", "Yihong" brand black tea and other famous green tea series products of Hubei Province.

Zhendong Group covers four major sectors: traditional Chinese and Western pharmaceuticals, health functional foods, health care products, and traditional Chinese medicine cultivation. It has eight industrial enterprises including Changzhi Zhendong, Datong Taisheng, Tunliu Wuhetang, Taiyuan Anxin, traditional Chinese medicine development, herbal medicine technology, Wuhe Medical and Nursing Hall, and health care. It has 32 subsidiaries and four research and development platforms. It is a health industry group with food safety certified by international HACCP and product testing certified by international CNAS (international recognition of drug, health functional food, and traditional Chinese medicine testing results), with total assets of 13.7 billion yuan.

Yabao Pharmaceutical Group Co., Ltd. established in 1978, it went public on the Shanghai Stock Exchange in 2002. Yabao Pharmaceutical adheres to the strategic approach of "Pediatrics First, Adult Medicines Supplement, Investment & Innovation." Guided by clinical demands, led by internationalization, and driven by talent and technology, the company focuses on pediatrics. It has implemented a comprehensive layout in various areas such as innovative drugs, complex generic drugs, Traditional Chinese Medicine, and comprehensive health products. The company has established a national-level enterprise technology center, post-doctoral research stations, and academician workstations. It possesses over 1000 intellectual property rights, including authorized patents, registered trademarks, and copyrights. The company has established nine major production bases and three R&D bases，and multiple production lines have been certified by developed countries such as the United States, Germany, and Japan. 

--

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. In 1994, Novo Nordisk established its commercial operations in China, and built a local presence across the full value chain covering R&D, production, and commercial operations within the first three years. Deeply rooted in China for longer than three decades, Novo Nordisk has been continuously expanding investment and deepening the full value chain presence to better serve Chinese patients.

Philips is a leading health technology company focused on improving people's lives across the health continuum- from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced techonologies and deep clinical and consumer insights, Philips delivers integrated solutions that address the Quadruple Aim: improved patient experience, better health outcomes, improved staff experience, and lower cost of care. At Philips, our vision is to make the world healthier and more sustainable through meaningful innovation and we aim to improve 2.5 billion lives per year by 2030.

Starbucks Coffee Company was founded in 1971. It is the leading roaster and retailer of specialty coffee in the world and one of the Global Fortune 500 companies in 2024. Starbucks remains committed to excellence in quality and service, following our mission and values to create a unique Starbucks experience for our customers every day through every great cup of coffee. Starbucks opened its first store in Mainland China in 1999 and now operates over 7,700 stores in over 1,000 county-level markets, employing more than 60,000 partners.